Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SWI/SNF Alterations in Squamous Bladder Cancers.
Achenbach F, Rose M, Ortiz-Brüchle N, Seillier L, Knüchel R, Weyerer V, Hartmann A, Morsch R, Maurer A, Ecke TH, Garczyk S, Gaisa NT. Achenbach F, et al. Among authors: weyerer v. Genes (Basel). 2020 Nov 19;11(11):1368. doi: 10.3390/genes11111368. Genes (Basel). 2020. PMID: 33227989 Free PMC article.
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation.
Morsch R, Rose M, Maurer A, Cassataro MA, Braunschweig T, Knüchel R, Vögeli TA, Ecke T, Eckstein M, Weyerer V, Esposito I, Ackermann M, Niegisch G, Gaisa NT; German Study Group of Bladder Cancer (DFBK e.V.). Morsch R, et al. Among authors: weyerer v. BMC Cancer. 2020 Mar 18;20(1):230. doi: 10.1186/s12885-020-06727-2. BMC Cancer. 2020. PMID: 32188412 Free PMC article.
TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers.
Weyerer V, Eckstein M, Strissel PL, Wullweber A, Lange F, Tögel L, Geppert CI, Sikic D, Taubert H, Wach S, Wullich B, Hartmann A, Stoehr R, Giedl J. Weyerer V, et al. Genes (Basel). 2021 Feb 5;12(2):230. doi: 10.3390/genes12020230. Genes (Basel). 2021. PMID: 33562516 Free PMC article.
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.
Zinnall U, Weyerer V, Compérat E, Camparo P, Gaisa NT, Knuechel-Clarke R, Perren A, Lugli A, Toma M, Baretton G, Kristiansen G, Wirtz RM, Cheng L, Wullich B, Stoehr R, Hartmann A, Bertz S. Zinnall U, et al. Among authors: weyerer v. Hum Pathol. 2018 Oct;80:55-64. doi: 10.1016/j.humpath.2018.05.022. Epub 2018 Jun 6. Hum Pathol. 2018. PMID: 29885409 Free article.
Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.
Weyerer V, Stoehr R, Bertz S, Lange F, Geppert CI, Wach S, Taubert H, Sikic D, Wullich B, Hartmann A, Eckstein M. Weyerer V, et al. World J Urol. 2021 Nov;39(11):4011-4019. doi: 10.1007/s00345-021-03788-1. Epub 2021 Jul 14. World J Urol. 2021. PMID: 34259899 Free PMC article.
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy.
Sikic D, Weyerer V, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, Schmitz-Draeger BJ, Wullich B, Hartmann A, Eckstein M. Sikic D, et al. Among authors: weyerer v. Urol Oncol. 2022 Feb;40(2):63.e19-63.e26. doi: 10.1016/j.urolonc.2021.07.025. Epub 2021 Aug 20. Urol Oncol. 2022. PMID: 34420870
33 results